{"nct_id":"NCT01406938","title":"Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens","status":"COMPLETED","status_verified_date":"2015-04","start_date":"2011-08","start_date_type":null,"primary_completion_date":"2013-05","primary_completion_date_type":"ACTUAL","completion_date":"2013-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}